The elimination of viral hepatitis in Canada: Where are we now and where can we go?
May 20, 2021 • By Shannon ElliotAt the last Canadian Liver Meeting in 2020, there was a palpable sense of optimism about the prospect of eliminating hepatitis C in Canada. Researchers, service providers and community members launched a blueprint outlining our collective goals and possible strategies, and we shared evidence from research and practice to guide policy and programs. Then the COVID-19 pandemic happened. It had an enormous impact on our sector, with services scaled back, researchers and clinicians shifted to the COVID-19 response, and the communities most affected by hepatitis C also facing increased risks from COVID-19 and a growing overdose crisis.